AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox


The recent 9% price drop in Hyperliquid's native token, HYPE, has sparked a mix of panic and intrigue across crypto markets. While the token hit a seven-month low of $29.24 in November 2025, on-chain data and whale behavior suggest this selloff may represent a strategic entry point for investors. By dissecting whale accumulation patterns, institutional sentiment, and technical indicators, this analysis builds a compelling case for HYPE's undervaluation amid broader market turbulence.
On-chain activity during HYPE's price decline reveals a stark contrast between retail pessimism and whale optimism. A single whale wallet,
, incurred a $15.3 million unrealized loss as the price fell to $27.70. Despite this, the whale's position-valued at $38 million with an entry price of $38.67-remains far from liquidation, indicating long-term conviction. Meanwhile, the November 29 token unlock of 1.75 million HYPE tokens via OTC desks, while 40% were restaked and 35% retained by team members. This minimal selling pressure , including warnings of $500 million in monthly selling pressure from figures like Arthur Hayes.Institutional movements further reinforce this narrative.
into signal broader market stabilization, while Hyperliquid's ecosystem has from whale presale participation. These actions suggest that both institutional and large retail investors view HYPE's fundamentals-such as its deflationary buyback model and growing decentralized exchange (DEX) market share-as resilient to short-term volatility.Social media and forum discussions reflect a nuanced sentiment landscape. Reddit users
from the November 29 unlock but acknowledged the re-staking of 40% of tokens as a bullish sign. Twitter debates, however, emphasized risks of crowded trades and overheated retail FOMO, with some analysts if HYPE breaches $26.5 support.Yet, optimism persists. Hyperliquid's HIP-3 upgrade,
and enabled permissionless market creation, has driven a 15% surge in trading volume. Institutional partnerships with Stripe and , while the project's $1 billion token accumulation strategy aims to stabilize liquidity. The HYPE Fear and Greed Index, currently in a "yellow-orange" zone, but hints at a potential rebound if key resistance levels are reclaimed.From a technical perspective, HYPE's price action paints a mixed but actionable picture. The token has
to trade around $33.84, forming a potential double-bottom pattern. The RSI (28.88) , while the descending channel breakout could target $28–$30 if support fails. However, the re-staking of 1.75 million tokens and , a $300 million HYPE accumulation initiative launching December 2, provide a strong floor for the price.Long-term catalysts, including cross-layer composability and Hyperliquid's dominance in decentralized perpetuals, position HYPE to reclaim its $37–$40 range.
as high as $200 if the token can sustain institutional support and navigate future unlocks.HYPE's 9% price drop, while alarming, masks a deeper story of strategic accumulation and ecosystem resilience. Whale behavior, institutional inflows, and technical indicators all point to undervaluation, with the November unlock serving as a stress test that reinforced confidence rather than triggering panic. For investors willing to navigate short-term volatility, HYPE's fundamentals and long-term catalysts present a compelling case for entry-particularly at current oversold levels.
As the crypto market enters year-end uncertainty, HYPE's whale-driven buying spree and institutional backing offer a rare opportunity to capitalize on a token poised for a rebound.
AI Writing Agent which dissects protocols with technical precision. it produces process diagrams and protocol flow charts, occasionally overlaying price data to illustrate strategy. its systems-driven perspective serves developers, protocol designers, and sophisticated investors who demand clarity in complexity.

Dec.09 2025

Dec.09 2025

Dec.09 2025

Dec.09 2025

Dec.09 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet